Increased hippocampal volume and gene expression following cognitive behavioral therapy in PTSD by Ahmed A. Moustafa
GENERAL COMMENTARY
published: 07 November 2013
doi: 10.3389/fnhum.2013.00747
Increased hippocampal volume and gene expression
following cognitive behavioral therapy in PTSD
Ahmed A. Moustafa*
Marcs Institute for Brain and Behaviour, School of Social Sciences and Psychology, University of Western Sydney, Sydney, NSW, Australia
*Correspondence: a.moustafa@uws.edu.au
Edited by:
Alexander J. Shackman, University of Maryland, USA
Reviewed by:
Talma Hendler, Tel Aviv University and Tel Aviv Medical Center, Israel
Keywords: PTSD, hippocampus, amygdala, neurogenetics, cognitive behavioral therapy, computational modeling
A commentary on
Association among clinical response,
hippocampal volume, and FKBP5 gene
expression in individuals with posttrau-
matic stress disorder receiving cognitive
behavioral therapy
by Levy-Gigi, E., Szabo, C., Kelemen, O.,
and Keri, S. (2013). Biol. Psychiatry. doi:
10.1016/j.biopsych.2013.05.017
In a recent study in Biological Psychiatry,
Levy-Gigi et al. found that a 12 weekly 90-
mins cognitive behavioral therapy (CBT)
treatment in individuals with posttrau-
matic stress disorder (PTSD) is associated
with an increase in hippocampal volume
and expression of glucocorticoid recep-
tor genes, known as FKBP5 (Levy-Gigi
et al., 2013). This is one of the few stud-
ies that have investigated the effects of
CBT on changes in brain volumes as well
as gene expression in individuals with
PTSD. The Levy-Gigi et al. study comple-
ments prior studies showing that antide-
pressant treatment is also associated with
increased hippocampal volume in psychi-
atric patients, including PTSD and depres-
sion (Vermetten et al., 2003). Despite
the positive effect of psychopharmaco-
logical and behavioral therapy in PTSD,
it is not known whether CBT and psy-
chopharmacological treatments are associ-
ated with dissociable effects on the brain
and behavior.
Interestingly, Levy-Gigi et al. found
that CBT ameliorates all aspects of PTSD,
including avoidance, re-experiencing, and
hyperarousal symptoms. However, it is
not clear from the Levy-Gigi et al.
study whether changes to the hippocam-
pal volume are associated with amelio-
ration to which PTSD symptoms. Prior
studies show that there is a trend for a
negative correlation between higher re-
experiencing symptoms and hippocampal
volume (Shucard et al., 2012), perhaps
suggesting that re-experiencing symptoms
are more ameliorated than other PTSD
symptoms following CBT treatment.
At the neural level, several studies show
that PTSD is associated with abnormalities
to various brain areas, including reduced
activity and volume of the hippocam-
pus (Gilbertson et al., 2002; Smith, 2005),
reduced activity of the ventromedial pre-
frontal cortex (Shin et al., 2005; Phan et al.,
2006), increased activity of the dorsal ante-
rior cingulate cortex (Shin et al., 2011),
and increased activity of the amygdala
(Armony et al., 2005; Shin et al., 2005).
However, why would CBT lead to changes
to the volume of the hippocampus but not
the amygdala or other cortical structures,
as found in the Levy-Gigi et al. study?
Prior studies have shown the hippocampal
volume is a risk factor for the develop-
ment of PTSD (Gilbertson et al., 2002),
while changes to amygdala, the ventrome-
dial prefrontal cortex, and dorsal anterior
cingulate cortex are acquired following
trauma exposure. This perhaps suggests
that changes to hippocampal volume fol-
lowing CBT can help protect against future
occurrences of PTSD symptoms.
How can hippocampal dysfunction be
related to PTSD symptoms? As noted by
Levy-Gigi et al., the ventral hippocampus-
amygdala pathway has been shown to
be related to increased stress and anxi-
ety (Fanselow and Dong, 2010). Further,
many animal and human studies show that
the hippocampus is involved in contextual
fear responses (Anagnostaras et al., 1999;
Corcoran and Maren, 2001; Ji and Maren,
2007; Acheson et al., 2012), such that
hippocampal damage leads to increased
fear response regardless of the context.
fMRI studies have also reported greater
hippocampus activation during contextual
than cue conditioning (Marschner et al.,
2008). In a prior computational model,
Moustafa et al. (2013) show that the
hippocampal region processes contextual
information and sends representations of
context to the basolateral amygdala and
ventromedial prefrontal cortex for fear
acquisition and extinction learning [for a
review, see Rudy et al. (2004); Goosens
(2011)], which help decrease and increase
fear responses within that context. It is also
not clear in the Levi-Gigi et al. study how
changes to the hippocampal volume ame-
liorate PTSD symptoms. Moustafa et al.
(2013) suggest that hippocampal projec-
tions to the ventromedial prefrontal cor-
tex and/or basolateral amygdala could be
enhanced by CBT treatment, which then
lead to a decrease in fear responses when
faced with a reminder of the trauma. This
hypothesis can be confirmed or discon-
firmed using diffusion tensor imaging in
both individuals and animal models of
PTSD [see for example Ding et al. (2013)].
The Levy-Gigi et al. study also
showed that CBT alters the expression
of genes, including the FKBP5 gene.
FKBP5 regulates glucocorticoid recep-
tor sensitivity, and reduce the efficacy of
cortisol in the brain (Mahon et al., 2013).
Polymorphisms in the FKBP5 gene relate
to differences in glucocorticoid receptor
sensitivity and stress hormone system reg-
ulation (Menke et al., 2013) as well as
recovery from stress disorders (Ising et al.,
2008) and rapid response to antidepres-
sant treatment (Binder et al., 2004). As
noted by Levy-Gigi et al., individual dif-
ferences in the FKBP5 gene are associated
Frontiers in Human Neuroscience www.frontiersin.org November 2013 | Volume 7 | Article 747 | 1
HUMAN NEUROSCIENCE
Moustafa Hippocampus, CBT, and PTSD
with anxiety disorders, including PTSD
(Xie et al., 2010; Boscarino et al., 2012).
Along these lines, Felmingham et al.
(2013) found that individual differences
in the brain-derived neurotrophic factor
(BDNF) gene predicts the efficacy of expo-
sure therapy in individuals with PTSD. It
remains to be shown whether BDNF gene
expression also undergoes changes follow-
ing either CBT or exposure therapy, and
whether exposure therapy affects the hip-
pocampal volume.
Future computational modeling work
is needed to explain how changes to the
hippocampal volume and gene expression
can ameliorate PTSD symptoms [see for
example Krasne et al. (2011); Li et al.
(2011); Moustafa et al. (2013)]. These
computational models should also tie
together brain volume and gene expression
data in one framework to explain how clin-
ical treatments can ameliorate symptoms
in PTSD.
In summary, Levy-Gigi et al. (2013)
have extended prior studies and shown
that the hippocampus is a key brain struc-
ture that benefits from CBT. Future work
should focus on network changes of hip-
pocampus projections to the amygdala
and ventromedial prefrontal cortex dur-
ing behavioral and psychopharmacologi-
cal treatments in PTSD.
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